Related Experiment Videos
An experimental study using sodium salicylate to reduce cochlear changes induced by furosemide
Archives of Oto-Rhino-Laryngology
|January 1, 1986
Summary
Sodium salicylate significantly reduces furosemide-induced ototoxicity by protecting the cochlear microstructures. This protective effect may involve prostaglandin pathways or organic acid uptake inhibition in the inner ear.
Area of Science:
- Ototoxicology
- Pharmacology
- Auditory Neuroscience
Background:
- Furosemide, a loop diuretic, is known to cause ototoxicity, primarily affecting the stria vascularis.
- Ototoxic effects of furosemide are linked to shrinkage and edema of the stria vascularis, correlating with electrophysiologic changes.
Purpose of the Study:
- To investigate the interaction between sodium salicylate and furosemide on cochlear microstructures.
- To determine if sodium salicylate can mitigate the ototoxic effects of furosemide.
Main Methods:
- Experiments were conducted on chinchillas (400-600 g).
- Endocochlear potential (EP) was continuously monitored via microelectrode insertion.
- Animals received either saline (control) or sodium salicylate intravenously 30 minutes before furosemide administration.
Main Results:
- Control animals showed a mean decrease in EP of 61.1 ± 7.0 mV after furosemide injection.
- Animals pre-treated with sodium salicylate exhibited a significantly smaller EP alteration (18.7 ± 3.9 mV) following furosemide.
Conclusions:
- Sodium salicylate markedly reduces the ototoxic effects of furosemide.
- This protective mechanism may involve modulation of prostaglandin metabolism or inhibition of organic acid uptake in the cochlea.